Management Team

Franco Stevanato resumed his role as Chief Executive Officer of Stevanato Group in May 2024. He previously served as Executive Chairman of the Board and led the Group as CEO from 2010 to 2020.
Franco is responsible for leading the company's global expansion, as well as the transformation of its core strategic objectives, and unique value proposition as an integrated solutions provider to pharma and biotech. Under his guidance, he led the Group to consistent growth underscored by its primary business pillars - biopharmaceutical and diagnostic solutions, engineering equipment, and analytical services - driving growth from €143 million in revenue in 2010 to over €1.1 billion in 2024.
Before joining Stevanato Group, Franco began his career in sales at Saint-Gobain in France. He holds a bachelor's degree in political science from the University of Trieste and completed the advanced management program at the Kellogg School of Management at Northwestern University.

Riccardo Butta holds a master’s degree in mechanical engineering from Politecnico in Milan, a degree in Business Management and Innovation from MIP in Milan and successfully completed the Executive Leadership Development Program from Stanford University in Palo Alto, California. Riccardo was the Senior Vice President of Flex Health Solutions, responsible for the global commercial organization of a Flex business unit providing contract design, manufacturing, and logistics services to the healthcare industry with focus on medical devices, drug delivery solutions, diagnostics and life sciences equipment. During his tenure at Flex, Riccardo was also responsible for the European organization of Flex Health Solutions, for the global device development organization, and for scale-up and management of the design center in Milan. In February 2022 Riccardo joined Stevanato Group as President Americas, overseeing the growth of the Group's in the area, as well as the expansion of the commercial offering around high value products and services.

Graduated from Ca’ Foscari University of Venice in 1997 in Business Administration. Mr. Dal Lago joined Stevanato Group in January 2020 as Chief Financial Officer. Marco brings 25 years of experience in the fields of controlling, finance, administration, compliance, and risk management, working in multinational industrial companies and coordinating multi-year planning and, mergers & acquisitions processes. In his current role, Marco oversees all administration, financial and controlling responsibilities for Stevanato Group.

More than 25 years of international experience in the fast-moving consumer goods industry, both in family business and multinational listed companies, developing and managing HR business partner organizations and people strategic plans to support the international growth of the company, both organically and by acquisitions. Paolo is responsible for developing and executing the Human Resources and Organization strategy to support Stevanato Group Business Plan and strategic direction, focusing on talent management, change management, organizational and performance development processes, succession planning, diversity & inclusion, while fostering Values & Guiding Principles adoption and Customer Centricity promotion.

Ugo Gay brings more than 30 years of international management experience in the pharmaceutical and diagnostics industries. He joined Stevanato Group in 2024 as Chief Operations Officer. Ugo began his career in 1995 at the Istituto Biologico Chemioterapico in Turin, where he became CEO of a subsidiary in 1998. In 2000, he joined Diasorin as Sales Director for the Italian market, where he held various leadership roles during his tenure, including Vice President on the Board of Assobiomedica and the European Diagnostic Manufacturers Association (EDMA). In 2012, he transitioned to Diasorin's Industrial Operations Group (EMEA) and was appointed Senior Vice President of Corporate Industrial Operations in 2019. Following the spin-off of a business unit in 2022, he became CEO and General Manager of the new subsidiary, Diasorin Italia S.p.A.. He holds a degree from the SDA Bocconi School of Management in Milan.

With more than 25 years of extensive business development experience, Mauro Stocchi joined Stevanato Group in 2004 and has held a variety of key management positions throughout his tenure, including Corporate General Manager and Chief Financial Officer.  Mauro currently serves as Stevanato Group's Chief Business Strategy Officer, where he oversees all strategic business development activities, including sales, product management, corporate development, strategic marketing, and supply chain management.  He previously spent a decade with Siemens Group, and prior to that, he commenced his career at De Longhi S.p.A. Mauro earned a master’s degree in business administration from SDA Bocconi in Milan and holds a bachelor’s degree from Ca’ Foscari University of Venice. 

With more than 25 years of experience, Lisa Miles joined Stevanato Group in 2021 as Senior Vice President of Investor Relations and then assumed the role of Chief Communications and Investor Relations Officer in 2024. Lisa currently is responsible for the Group’s global communications, media, and brand strategy, as well as the investor relations function. Previously, Lisa spent 18 years at Maximus in various management positions. In her most recent role, she served as Senior Vice President of Investor Relations & Corporate Communications for nearly a decade where she was responsible for investor relations, global marketing and branding, media relations, and employee communications. Named to the 2017 and 2018 Institutional Investor’s All America Executive Team for Midcap Investor Relations, Lisa was ranked third for Best Midcap IR Professionals in the Business, Education, and Professional Services sector. She holds a bachelor’s degree in communications from the Pennsylvania State University and completed an executive leadership program in management and negotiation at the Harvard Business School.